Description
OVERVIEWProduct overview
This vial contains BPC-157 and TB-500 blended before lyophilisation, so a single reconstitution produces a solution containing both peptides.
It is used where a combined condition is being compared against single-compound arms, and it removes one reconstitution step from the protocol.
Both peptides are experimental research compounds. Neither is licensed for human or veterinary use.
SUPPLY IN IRELANDBPC-157 & TB-500 Ireland — supplied to research laboratories
Research groups across Ireland buy BPC-157 & TB-500 from Kensington Laboratories as a lyophilised BPC-157 & TB-500 peptide, released only against a batch-matched certificate of analysis. Every vial of high purity BPC-157 & TB-500 is verified by HPLC and LC-MS before it leaves the facility, so laboratories ordering BPC-157 & TB-500 in Ireland receive material with documented purity and identity.
Laboratory BPC-157 & TB-500 is packed for controlled storage and sent by tracked delivery in 3–5 days to Dublin, Cork, Galway, Limerick and the rest of Ireland. Delivery costs €9.90 per order. Teams planning BPC157&TB500 research can review the specifications, certificate of analysis and reference list on this page before ordering.
Institutions searching for BPC-157 & TB-500 peptide suppliers in Ireland typically compare purity, batch documentation and delivery times. Each of those is published here: a 99% HPLC purity specification, a certificate matched to the batch code on your vial, and tracked delivery in 3–5 days.
BPC-157 & TB-500 is supplied strictly for laboratory research use only. It is not a medicine and is not for human or veterinary consumption.
SPECIFICATIONSProduct specifications
- Purity: ≥ 99% (HPLC)
- Appearance: White lyophilised powder
- Quantity: 10 mg total or 20 mg total per vial
- Peptide class: Pre-blended lyophilised vial containing both peptides
- Also known as: Repair peptide blend
- Solubility: Soluble in bacteriostatic or sterile water
- Storage temperature: Store at 2–8°C; long-term −20°C, protected from light
- Shelf life: 24 months lyophilised; 30 days reconstituted at 2–8°C
- Manufacturing standard: ISO 9001 facility, GMP-aligned solid-phase synthesis
- Batch information: Batch number and expiry printed on every vial label
RESEARCHResearch overview
The following summary is provided for educational and scientific context only. It describes what has been observed in published laboratory and animal studies and does not represent established clinical outcomes, medical advice or a claim of efficacy in humans.
Background
This vial contains BPC-157 and TB-500 blended before lyophilisation, so a single reconstitution produces a solution containing both peptides.
It is used where a combined condition is being compared against single-compound arms, and it removes one reconstitution step from the protocol.
Both peptides are experimental research compounds. Neither is licensed for human or veterinary use.
Current research areas
Published investigation clusters around a small number of biological themes. Each remains experimental and none has been established as a therapeutic effect in humans.
- Combined repair-pathway conditions compared against single-peptide arms
- Fibroblast activity and collagen organisation in experimental healing
- Cell migration and actin dynamics in soft tissue models
- Angiogenic signalling in wound and ischaemia models
Scientific context and proposed mechanisms
BPC-157 is discussed in the literature in relation to fibroblast behaviour, collagen organisation and nitric-oxide signalling; TB-500 through actin binding and cell migration.
Because the two are supplied pre-mixed, any observed effect cannot be attributed to one peptide without a matched single-compound control arm.
Interpreting the evidence
Most published work in this area uses cell culture or rodent models with small group sizes and short observation windows. Independent replication varies considerably between compounds, and results are sensitive to species, route, dose and endpoint.
There is no regulatory-approved human protocol for this compound. Any laboratory protocol should be defined by the model under study, institutional ethical approval, appropriate controls and predefined endpoints.
References
CERTIFICATE OF ANALYSISIndependent batch testing
Every released batch is independently tested. Match the batch number on the vial to the certificate published online.
- Batch number
- KL-BPC157TB50-2408A
- Testing laboratory
- Colmaric Analyticals
- Date tested
- 21 July 2026
- Reported purity
- 99.63%
- Method
- RP-HPLC with UV detection at 214 nm, confirmed by LC-MS
The independent result for this batch is summarised above. Contact the laboratory team if you need the full report for this batch.
